Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I suppose many are watching the price increase and wondering

Almost out of delisting territory. Thought we had gone by that deadline date several weeks ago. Wonder if we received a waiver from nasdaq because this settlement was in the works. Hope nasdaq and shareholders are not disappointed if this deal with TPL fails to increase share value, again.

Share
New Message
Please login to post a reply